We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
268 result(s) found, displaying 41 to 50
-
Cancellation by sponsorRequested by Janssen-Cilag Pty Ltd
-
Australian public assessment report (AusPar)Tecvayli (teclistamab) has been provisionally approved for the treatment of relapsed or refractory multiple myeloma in adult patients.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TECVAYLI teclistamab 90mg/mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for TECVAYLI teclistamab 10mg/mL solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Cellular Therapies - T cells-Ciltacabtagene autoleucel, cryopreserved-T-CARVYKTI - Janssen-Cilag Pty Ltd - Injection, intravenous infusion - Bag.
-
-
Cancellation by sponsorRequested by Janssen-Cilag Pty Ltd
-
Cancellation by sponsorRequested by Janssen-Cilag Pty Ltd
-
Cancellation by sponsorRequested by Janssen-Cilag Pty Ltd
-
Cancellation by sponsorRequested by Janssen-Cilag Pty Ltd